Efficacy of Sildenafil in the Treatment of Female Sexual Dysfunction Due to Multiple Sclerosis

Sildenafil > sildenafil for women


While the safety profile is acceptable, the lack of significant benefits underscores sildenafil chewable tablets the need for more targeted research.

  • Some studies have shown mild improvements in female sexual distress.
  • The drug may help women with orgasmic disorder by increasing sensation.
  • Women should report any unusual symptoms to a healthcare professional.
  • Alternative treatments include counseling and hormonal therapy.

Future studies should focus on identifying specific subgroups of women who may respond to sildenafil and exploring alternative treatment options to address the complex nature of female sexual dysfunction. The content presented in this blog is generated by Consensus, an AI-powered academic search engine, and is based on publicly available scientific literature.

How Viagra Works

The efficacy was assessed using various tools, including global efficacy questions (GEQ), the Life Satisfaction Checklist (LSC), sexual activity event logs, and a 31-item sexual function questionnaire (SFQ). The study's results indicated that there were no significant differences in efficacy between sildenafil and placebo for any of the measured endpoints, including the GEQ, sexual event logs, LSC, and SFQ1. This suggests that sildenafil did not significantly improve the sexual response in women with FSAD, regardless of their estrogen status. Additionally, the main adverse events reported were headache, flushing, rhinitis, nausea, visual disturbances, and dyspepsia, which were generally mild to moderate in nature. While the study found that sildenafil was generally well-tolerated, the adverse events reported highlight the importance of considering potential side effects when evaluating this treatment option for women.

Effects on sexual dysfunction

The safety profile of sildenafil in women appears to be similar to that observed in men, with common side effects being relatively mild. The study concluded that any genital physiological effect of sildenafil was not perceived as improving the sexual response in the broad spectrum of women with FSAD who participated in the trial1. However, it also suggested that future research could explore whether more specific subgroups of women with FSAD might benefit from sildenafil treatment. This indicates a need for further studies to identify potential responders and optimize treatment protocols. The quest for a 'Female Viagra' continues, with sildenafil citrate showing limited efficacy in improving sexual response in women with FSAD. While every effort is made to provide accurate, up-to-date, and well-researched information, the content is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions regarding medical conditions, treatments, or medications.

  • Sildenafil’s interaction with other medications is an important consideration.
  • It has a different impact depending on individual health conditions.
  • Data on long-term effects of sildenafil in women are inconclusive.
  • Use only under medical supervision to minimize risks.

The AI system's analysis may not cover all perspectives, emerging research, or individual cases, and it is not a substitute for professional expertise. Neither the blog publisher nor the developers of the AI-powered search engine are responsible for any actions taken based on the information provided in this content.

Product Dosage Quantity + Bonus Price
Viagra Generic200mg30 + 2 Pills83.07€ 79.11€
Kamagra Soft Tabs100mg32 Pills120.11€ 114.39€
Viagra Generic25mg10 Pills25.19€ 23.99€
Viagra Generic25mg360 + 10 Pills213.68€ 203.50€
Kamagra Polo100mg20 Pills83.56€ 79.58€
Viagra Generic200mg60 + 4 Pills125.19€ 119.23€
Viagra Generic50mg270 + 8 Pills198.48€ 189.03€
Viagra Generic50mg10 Pills26.87€ 25.59€
Viagra Generic50mg30 + 4 Pills54.26€ 51.68€
Viagra Generic150mg180 + 10 Pills236.46€ 225.20€
Viagra Generic100mg180 + 8 Pills199.37€ 189.88€
Kamagra Polo100mg180 + 8 Pills446.52€ 425.26€
Kamagra Soft Tabs100mg180 + 8 Pills425.45€ 405.19€
Kamagra Soft Tabs100mg84 + 4 Pills233.05€ 221.95€
Kamagra100mg84 + 6 Pills264.44€ 251.85€
Viagra Generic150mg60 + 4 Pills111.25€ 105.95€

Use of this information is at your own risk. Citations to the original scientific studies are included for reference, but these studies should be reviewed in full and interpreted with the guidance of a healthcare or research professional. If you are experiencing a medical emergency, please seek immediate attention from a healthcare provider.

Region Cost Range per Dose Availability Notes
North America $10-$25 Prescription only Off-label use limited
Europe €8-€20 Prescription, some OTC in countries Varies widely
Asia $5-$15 Often available OTC or via clinics Cost-effective options
Australia $15-$30 Prescription only Under medical supervision

Consensus searches through 220M+ peer reviewed research papers and provides you the best insights from them. In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin).

Common side effects

Quirk F, Haughie S, Symonds T. The use of the sexual function questionnaire as a screening tool for women with sexual dysfunction. Symonds T, Boolell M, Quirk F. Development of a questionnaire on sexual quality of life in women. Berman JR, Berman LA, Toler SM, Gill J, Haughie S.

Eur. Urol.

Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. Female sexual dysfunction (FSD) affects up to one third of women in the U.S., often involving low libido, arousal difficulties, and pain during intercourse. Viagra (sildenafil citrate) is approved to treat erectile dysfunction in men but is sometimes prescribed off‑label in women. Evidence is limited and mixed, and FSD often has multifactorial causes 150mg sildenafil for sale including hormonal changes, medications, relationship issues, and psychological factors. By blocking PDE‑5, it increases blood flow to genital tissues: In women, enhanced blood flow to the clitoris and labia may increase lubrication, sensitivity, and genital engorgement following sexual stimulation.

Sexual Health in the Neurogenic Patient

Sildenafil is also available under the brand Revatio at lower doses for pulmonary hypertension in both sexes. Some trials suggest benefit for women with arousal problems or SSRI‑induced sexual side effects, particularly in postmenopausal women. Other studies show minimal or no improvement. More research is needed to determine which subgroups of women might benefit. Allergic reactions: hives, facial or throat swelling, difficulty breathing Heart problems: chest pain, heart attack, irregular heartbeat Dangerous drop in blood pressure when combined with nitrates (nitroglycerin, isosorbide dinitrate) or certain blood pressure medications Prolonged erection (priapism) lasting more than 4 hours Addyi (flibanserin): taken daily at bedtime for premenopausal women with hypoactive sexual desire disorder. Some people may refer to these as “Viagra for females.” The Food and Drug Administration (FDA) have approved two drugs — flibanserin (Addyi) and bremelanotide (Vyleesi) — to address low desire or arousal in females.

  • Sildenafil can enhance arousal in women with sexual issues.
  • It works by relaxing blood vessels, increasing genital blood flow.
  • Dosage for women is not well established; consult a doctor.
  • Its effectiveness varies among women with sexual dysfunction.

However, both are approved for use only in people who have not yet entered menopause.

References (25)

Side effects include dizziness, fatigue, nausea, dry mouth, and insomnia. Vyleesi (bremelanotide): injected at least 45 minutes before sexual activity, up to 8 doses per month, for premenopausal women with low desire. Common side effects are nausea, flushing, injection site reactions, headache, and fatigue. Avoiding tobacco, excess alcohol, and recreational drugs Investigational supplements (L‑arginine, ginseng, maca, etc.) have limited evidence Safety and efficacy of sildenafil citrate in women with arousal disorder. Prevalence of low sexual desire in US women.

Mohamed Alhefnawy1*, Abdulla Esawy2, Mohamed Abdelazeem1, Mohamed Elnamoury3, Ahmed Eissa4, Ahmed Zoair4, Ahmed Ghaith4, Ayman Hagras4 and Khaled Almekaty4

This post was written with Consensus AI Academic Search Engine - please read our Disclaimer at the end of this article. The concept of a 'Female Viagra' has garnered significant attention in recent years, as researchers and pharmaceutical companies seek to address sexual dysfunction in women. Sildenafil citrate, commonly known as Viagra, is well-known for its efficacy in treating erectile dysfunction in men. However, its potential benefits for women with sexual dysfunction, particularly Female Sexual Arousal Disorder (FSAD), remain a topic of ongoing research and debate. Female Sexual Arousal Disorder is characterized by a persistent or recurrent inability to attain or maintain sufficient sexual excitement, causing personal distress.

Key takeaways

This condition can significantly impact a woman's quality of life and intimate relationships. The nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway, which plays a crucial role in penile erection, is also believed to be involved in the female sexual arousal response. This has led researchers to explore the potential of sildenafil citrate in treating FSAD. A study aimed at evaluating the efficacy and safety of sildenafil citrate in women with sexual dysfunction, including FSAD, provides valuable insights into this potential treatment option1. The study involved 577 estrogenized and 204 estrogen-deficient women who were randomized to receive either sildenafil (10-100 mg) or a placebo. This article describes the FDA-approved medications for low libido in females, including how they work and the possible side effects. This article will use the terms “male,” “female,” or both to refer to sex assigned at birth. The FDA has approved two drugs to address FSIAD: Vyleesi (bremelanotide) and Addyi (flibanserin). Addyi was the first drug approved to treat FSIAD. Addyi is designed for premenopausal people, and is available as a pill.

Other Treatments for Low Libido

The Sexual Function Questionnaire, the Sexual Quality of Life Questionnaire-Female, a global efficacy question and Sexual Distress Question were also assessed. Results: Sildenafil-treated women and placebo-treated women had an increase in their percentage of sexual activities throughout the course of the study, with no statistically significant difference between groups in the percentage of successful sexual activities at end of treatment versus baseline. There were also no statistically significant differences between sildenafil-and placebo-treated women on the aforementioned measures. Conclusion: The results of this study are similar to other reports regarding a lack of clinically meaningful benefit of sildenafil in other populations of women. Targeting recovery: priorities of the spinal cord- injured population.

Female Sexual Dysfunction—Medical and Psychological Treatments, Committee 14

Sexual activities, response and satisfac- tion in women pre-and post-spinal cord injury. Sexual activities, desire, and satisfaction in males pre-and post-spinal cord injury. Arch Sex Behav 1993; 22: 217-228. Sipski ML, Alexander CJ, Rosen R. Sexual arousal and orgasm in women: effects of spinal cord injury.

Br. J. Obstet. Gynaecol.

Arch Sex Behav 2004; 33: 295-302. Hultling C, Giuliano F, Quirk F, Pen ˜a B, Mishra A, Smith MD. Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med 2002; 11: 277-289. A person takes this drug daily before bed, even if they do not intend to have sex that day. It can take no more than 8 weeks to see an increase in sexual desire, though some people experience the effects much sooner. The FDA states that Vyleesi medication can treat FSIAD in premenopausal females.

  • Sildenafil's effect duration in women may range from 4 to 6 hours.
  • It may help women experiencing low libido linked to blood flow issues.
  • The drug’s efficacy in women is less predictable than in men.
  • Female sexual dysfunction has multiple causes beyond blood flow.

A person injects it into their thigh or stomach at least 45 minutes before having sex. The effects can last for up to 24 hours. People should not use the drug more than eight times per month.

Drug Name Mechanism Approval Status Cost per Dose Common Side Effects
Sildenafil PDE5 inhibitor Not officially approved $10-$20 Headache, flushing
Tadalafil Longer duration, PDE5 inhibitor Limited use $15-$30 Muscle pain, headache
Vardenafil Similar to sildenafil Experimental $12-$25 Vision changes